Control of keratinocyte differentaiation by integrins

Informations projet

CAMPBELLDOUGLAS

N° de convention de subvention: QLG1-CT-1999-51256

Projet clôturé

Date de début 1 Janvier 2000

Date de fin 31 Decembre 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 113 872,00

Contribution de l’UE € 113 872,00

Coordonné par

Imperial Cancer Research Fund
United Kingdom

Objectif

Extracellular matrix receptors of the B1 integrin family regulate terminal differentiation of normal keratinocytes and are frequently mis-expressed in tumors. The aim of this proposal is to investigate the signalling pathways by which integrins control differentiation.

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

Imperial Cancer Research Fund

• Contribution de l’UE: Aucune donnée
• Adresse: Lincoln's Inn Fields 44 ; WC2A 3PX LONDON ; Royaume-Uni
• Coût total: Aucune donnée